21 March 2025
We are excited to announce the release of our latest Environmental, Social, and Governance (ESG) report. This detailed document showcases our significant achievements from November 2023 to October 2024, as well as describing all our ESG activities and processes.
News and events We are thrilled to announce a significant shift in our office model that will enhance our ability to attract top talent from across the USA, build a more flexible and sustainable culture, and – importantly – work from locations and time zones that are closer to our clients. Starting this year, we are transitioning…
We are excited to announce the release of our latest Environmental, Social, and Governance (ESG) report.
As HealthScience professionals, we spend a lot of time thinking about data. How many patients are there worldwide? How many days do these patients spend in hospital per year? How much more effective is drug X than drug Y? On Rare Disease Day, there are a lot of numbers to think about too. According to…
Graham Shelton, our Founder and Chairman, stepped down at the end of December 2024. We were proud to mark his retirement at our Oxford party, and present him with a book of memories from current and former colleagues and clients from around the world.
Revolutionizing pharma training: key takeaways from LTEN Unveiling the future of pharmaceutical training, we gathered invaluable insights at the Life Sciences Trainers & Educators Network (LTEN) Annual Conference. Training professionals are constantly striving for impactful learning experiences that not only educate, but also induce tangible behaviour change. Our Learning Design Team Lead, Jamie Singer, attended…
AI tools for systematic literature reviews AI can help us to develop high-quality work, including systematic literature reviews (SLRs) for publication. In this article, published in the September edition of The MAP, the official newsletter of the International Society for Medical Publication Professionals, Polly Field, Richard White and Tomas Rees from Oxford PharmaGenesis provide guidance…
